mounjaro o tirzepatide is second obesity drug to be approved for use in England | Obesity GIP and GLP Mounjaro (tirzepatide) DailyMed Drug Label

Researchers exploring microdosing GLP-1 for autoimmune conditions are targeting specifically this anti-inflammatory mechanism

Fatal events were more frequent in this population (110)

Can Your Regular Doctor Help You Qualify For GLP-1

Supports Tanning Photoprotective Lessens appetite and improves lipid and glucose regulation Libido enhancement (more of a side effect at a high dose) Metabolic Support: Lipolytic, appetite control, anti-inflammatory, lowers oxidative stress Induces enhanced thermogenic and anorexic responses Helps improve glucose and cholesterol metabolism Supports Immunity May help Autoimmune conditions

With any kind of weight loss, doing it properly and healthily will not only lead to the best results, but the most sustainable results